On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayJul 24, 2017 1:01 pm

NetworkNewsBreaks – Cytori Therapeutics, Inc. (NASDAQ: CYTX) Shares Plummet to New Low on Disappointing STAR Trial Results

Shares of Cytori Therapeutics (NASDAQ: CYTX) sunk to a new 52-week low of $0.45 following the company’s release of top-line preliminary data from its pivotal STAR trial of Habeo™ Cell Therapy in patients with scleroderma. Results show that statistical significance was not achieved in the primary endpoint, Cochin Hand Function Score (CHFS), or the secondary endpoint, Raynaud’s Condition Score. However, clinically meaningful efficacy trends were observed in both the efficacy endpoints. “We are disappointed that the study missed the primary and secondary endpoints. However, we are very encouraged by the trends toward improved hand function and scleroderma-related health status in…

Continue Reading

MondayJul 24, 2017 9:40 am

NetworkNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Subsidiary Files Record of ‘CBD Magic Hemp Series’ Product Line Ahead of Impending Launch

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., has officially filed a record of its first line of non-industrial hemp-infused skin care products with the China Food and Drug Administration (CFDA). These products, which comprise the new ‘CBD Magic Hemp Series’ skin care line, are expected to launch in late August and early September of this year, positioning CBD Biotechnology as a first-mover in an untapped segment of China’s skin care industry. “As one of the first skin care products containing CBD extract marketed in China, CBD Magic Hemp…

Continue Reading

MondayJul 24, 2017 9:11 am

NetworkNewsBreaks – ProBility Media Corp. (PBYA) Enters Binding Letter of Intent to Purchase Cranbury International

Education technology company ProBility Media Corp. (OTCQB: PBYA) this morning announced that it has signed a binding letter of intent to purchase Cranbury International, an exporter of educational and reference materials located in Montpelier, Vermont. The acquisition is expected to close within 30 days and will significantly expand ProBility’s reach in markets throughout South and Central America, as well as the Caribbean. Cranbury, which markets and represents roughly 40 major publishers, currently sells educational materials to government institutions and private sector markets in Brazil, Mexico, Columbia, Trinidad and other international regions. “The purchase of Cranbury complements ProBility's international strategy of…

Continue Reading

FridayJul 21, 2017 12:35 pm

NetworkNewsBreaks – TearLab Corp. (NASDAQ: TEAR) Shares Skyrocket on Regulatory Approval of Commercial TearLab Discovery™ System in EU

TearLab (NASDAQ: TEAR) shares are up 84% mid-day following news that the company’s commercial version of its TearLab Discovery™ System has met all the applicable provisions of In Vitro Diagnostic Medical Devices Directive 98/79 EC required for CE Marking. Regulatory clearance enables the company the ability to market in the European Union and European Free Trade Association member countries and expands regulatory clearance beyond the previously-cleared discovery device to include the first commercial test card. The company is expected to use this clearance to build a clinical data package in support of a 510(k) submission to the FDA, which is…

Continue Reading

FridayJul 21, 2017 12:33 pm

NetworkNewsBreaks – Brainstorm Cell Therapeutics, Inc. (NASDAQ: BCLI) Secures $16M Grant from CIRM toward Phase 3 Clinical Trial of NurOwn® in ALS

Shares of Brainstorm Cell Therapeutics (NASDAQ: BCLI) are up more than 8% this morning after the company said it has been awarded a grant of $16 million by the California Institute for Regenerative Medicine (CIRM) to support the pivotal phase 3 study of NurOwn® for the treatment of amyotrophic lateral sclerosis (ALS). This grant signifies an endorsement from CIRM of the company’s approach to treat ALS using adult stem cells. The phase 3 clinical trial investigating NurOwn in ALS is expected to enroll approximately 200 patients and will be measured by the ALSFR-S score responder analysis. "This substantial award provides…

Continue Reading

ThursdayJul 20, 2017 10:10 am

NetworkNewsBreaks – SRAX (NASDAQ: SRAX) Launches People-Based Advertising Guide for Effective Consumer Connection

Advertising technology company SRAX (NASDAQ: SRAX) this morning introduced a new guide to help digital marketers and content owners best utilize customer and user data to reach people in the advertising ecosystem. "Connecting with each consumer individually, across devices, platforms and publishers is critically important in today's digital advertising marketplace," SRAX chairman and CEO Christopher Miglino stated in the news release. "Our People-Based Advertising guide is designed to inform and inspire brands and agencies to unlock the ultimate level of cross-device targeting precision." People-Based Advertising: How to Get Bigger Results by Targeting the Most Precise Audience, is available to download…

Continue Reading

ThursdayJul 20, 2017 9:59 am

NetworkNewsBreaks – ProBility Media Corp. (PBYA) Launches Joint Venture with Industrial3D Corp. to Develop Virtual Reality Education and Training Products

EdTech innovator ProBility Media (OTCQB: PBYA) is venturing into the virtual reality realm through a new joint venture with Industrial3D Corp. ProBility Immersive Technologies will create virtual reality and interactive media content designed specifically for education and training purposes. With the joint venture, ProBility’s IP library encompasses over 200 animations applicable to industries it already serves and enables the  company to offer for the first time expanded subscription services to employers for training and education in the energy and industrial sectors. "Through our acquisition and partnership strategy, ProBility now offers a comprehensive suite of career training, career advancement and compliance…

Continue Reading

ThursdayJul 20, 2017 9:38 am

NetworkNewsBreaks – Net Element’s (NASDAQ: NETE) PayOnline Adds InSales Support, Gains Access to Over 4,000 New Merchants

Global financial technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE), through its PayOnline subsidiary, this morning announced the expansion of its payment module for electronic commerce and Content Management System (“CMS”) to include InSales, a popular omni-channel commerce and CMS platform aimed at small- to medium-sized businesses. In addition to supporting payments from the world’s most popular bankcards, such as Visa, Visa Electron, MasterCard, Maestro and MIR, the free PayOnline module for InSales supports a wide array of global currencies, including U.S. dollars, euros, rubles, tenge, soms, shekels and over 110 other currencies. Per this morning’s update, Net…

Continue Reading

ThursdayJul 20, 2017 9:05 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) Commences Lab Work with National Research Council of Canada

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) this morning announced the start of laboratory work under its collaborative research project with the National Research Council of Canada (“NRC”). “We are delighted to have commenced formulation development and characterization work together with the NRC,” John Docherty, president of Lexaria Bioscience, stated in the news release. “The NRC team has extensive knowledge and experience in the field of lipid based delivery systems relating to pharmaceutical products, natural health products and functional foods. This collaboration will significantly assist Lexaria in further developing and characterizing its IP portfolio.” Moving forward, several studies will be…

Continue Reading

WednesdayJul 19, 2017 1:23 pm

NetworkNewsBreaks – ORHub, Inc. (ORHB) Shares Spike on Launch of Cardiac and Cardiology Service Line, Overall Deployment Strategy

Shares of ORHub (OTC: ORHB) are up nearly 5% after the company said that it is on track to exceed its deployment goals for 2017 with the launch of its Cardiac and Cardiology service line, the third line in its portfolio of medical software modules. ORHub's Cardiac and Cardiology service line is expected to be available in early third quarter 2017. "The ORHub Platform helps hospitals and surgeons make real-time, data-driven decisions that improve business profitability and patient outcomes. Utilizing the resources of our new national delivery partner, we intend to expand our service line offerings at an aggressive rate…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217